𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2+patients with hormone-refractory prostate cancer

✍ Scribed by Satoko Matsueda; Kazuhiko Kobayashi; Yoichi Nonaka; Masanori Noguchi; Kyogo Itoh; Mamoru Harada

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
472 KB
Volume
53
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prostate stem cell antigen: Identificati
Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients
✍ Andrea Kiessling; Marc Schmitz; Stefan Stevanovic; Bernd Weigle; Kristina HΓΆlig; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 187 KB

Identification of TAAs recognized by CD8(+) CTLs paved the way for new concepts in cancer therapy. In view of the heterogeneity of tumors and their diverse escape mechanisms, CTL-based cancer therapy largely depends on an appropriate number of TAAs. In prostate cancer, the number of antigens defined

Infusion of dendritic cells pulsed with
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
✍ Murphy, G.P.; Tjoa, B.A.; Simmons, S.J.; Jarisch, J.; Bowes, V.A.; Ragde, H.; Ro πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 2 views

## Background: A phase ii trial was conducted to assess the efficacy of infusions of dendritic cells (dc) and two hla-a2-specific psma peptides (psm-p1 and -p2). this report describes thirty three subjects with hormone-refractory metastatic prostate cancer without prior vaccine therapy history who

Report of immune monitoring of prostate
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)
✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 336 KB πŸ‘ 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut